The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program
Abstract
OBJECTIVES: Use of buprenorphine - an effective treatment for opioid use disorders (OUDs) - has increased rapidly in recent years and is often financed by Medicaid. We investigated predictors of buprenorphine treatment, patterns of care, and quality of care in a large state Medicaid program. METHODS: Data from Pennsylvania Medicaid from 2007 to 2012 provided information regarding diagnoses, demographic characteristics, enrollment, and use of inpatient and outpatient services, and prescription drugs. We identified adult enrollees using buprenorphine, and examined prevalence of OUD diagnosis and patterns of use (duration and dose) and quality of care (physician visits, receipt of behavioral health counseling, urine drug screens, and other prescription drug use). We use a mixed logistic regression model to examine enrollee characteristics associated with buprenorphine use. RESULTS: The share of enrollees with OUD filling prescriptions for buprenorphine increased from 2985 (9.8%) to 12,691 (25.2%) from 2007 to 2012. Between 26.2 and 32.0% of enrollees using buprenorphine had no diagnosis of OUD, depending on the year. Only 60.1% of enrollees with buprenorphine use received at least one urine drug screen, 41.0% had behavioral health counseling services, and 34.7 and 38.0% had other opioid and benzodiazepine claims, respectively, concomitant with buprenorphine use. Quality of care was lower among those with no OUD diagnosis recorded. The mean daily doses of buprenorphine decreased over time. We found wide variation in likelihood of buprenorphine use among those with OUD based upon age, sex, and race. CONCLUSIONS: Increases in buprenorphine treatment in a Medicaid population were observed across time; however, increases varied by age, sex, and rate, and the quality of care received seemed to be generally poor. The quality of the provision of buprenorphine treatment occurring in Medicaid populations should be further explored.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“patients often drop out of medication treatment [50, 51].”
From Translating economic evaluations into financing strategies for implementing evidence-based practices (2021) · cites this paper as [50]
In the citing paper
“it remains underutilized”
From Translating economic evaluations into financing strategies for implementing evidence-based practices (2021) · cites this paper as [50]
Citations
Cites
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C. L., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,312
Applied Mixed Models in Medicine
Brown, H., & Presco, R. (2000) · Technometrics · doi:10.1080/00401706.2000.10485742 · Cited by 1,699
Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic
Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1402780 · Cited by 1,014
Psychiatric and Substance Use Comorbidity Among Treatment-Seeking Opioid Abusers
Brooner, R. K. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130077015 · Cited by 745
Fudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., Collins, J., Raisch, D., Casadonte, P., Goldsmith, R. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022164 · Cited by 577 · cited 2×
“…using buprenorphine (eitherbuprenorphine monotherapy or buprenorphine/naloxone pharmacotherapy) is an evidence-based, cost effective treatment for opioid use disorder (OUD) (Fudala et al., 2003; Fiellin et al., 2006; Barnett, 2009; Jones et al., 2009; Mattick et al., 2014; Volkow et al., 2014).”
BackgroundMethodWeiss, R. D. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.121 · Cited by 540
Geographic and Specialty Distribution of US Physicians Trained to Treat Opioid Use Disorder
Rosenblatt, R. A., Andrilla, C. H. A., Catlin, M., & Larson, E. H. (2015) · The Annals of Family Medicine · doi:10.1370/afm.1735 · Cited by 380
Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid Dependence
Fiellin, D. A., Pantalon, M. V., Chawarski, M. C., Moore, B. A., Sullivan, L. E., O'Connor, P. G., & Schottenfeld, R. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055255 · Cited by 351
Office-Based Management of Opioid Dependence with Buprenorphine: Clinical Practices and Barriers
Walley, A. Y., Alperen, J. K., Cheng, D. M., Botticelli, M. P., Castro-Donlan, C., Samet, J. H., & Alford, D. P. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0686-x · Cited by 219
KIDORF, M. S., Disney, E. R., King, V. L., Neufeld, K. J., Beilenson, P. L., & Brooner, R. K. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.11.014 · Cited by 178
Trends in abuse and misuse of prescription opioids among older adults
West, N. A., Severtson, S. G., Green, J. L., & Dart, R. C. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.027 · Cited by 165
A Randomized Trial of Cognitive Behavioral Therapy in Primary Care-based Buprenorphine
Fiellin, D. A., Barry, D. T., Sullivan, L. E., Cutter, C. J., Moore, B. A., O’Connor, P. G., & Schottenfeld, R. S. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.07.005 · Cited by 160
Office-Based Treatment of Opioid-Dependent Patients
Fiellin, D. A., & O'Connor, P. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013579 · Cited by 148
Supply of buprenorphine waivered physicians: The influence of state policies
Stein, B. D., Gordon, A. J., Dick, A. W., Burns, R. M., Pacula, R. L., Farmer, C. M., LESLIE, D. L., & Sorbero, M. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.07.010 · Cited by 110
Self-citationStein, B. D., Gordon, A. J., Sorbero, M., Dick, A. W., Schuster, J., & Farmer, C. M. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.10.016 · Cited by 96
Self-citationAdelmann, P. K. (2003) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1023/b:apih.0000003017.78877.56 · Cited by 89
State policy influence on the early diffusion of buprenorphine in community treatment programs
Ducharme, L. J., & Abraham, A. J. (2008) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-3-17 · Cited by 88
Clark, R. E., Samnaliev, M., Baxter, J. D., & Leung, G. Y. (2011) · Health Affairs · doi:10.1377/hlthaff.2010.0532 · Cited by 85
Abuse and diversion of buprenorphine sublingual tablets and film
Lavonas, E. J., Severtson, S. G., Martinez, E. M., Bucher‐Bartelson, B., Lait, M. L., Green, J. L., Murrelle, L., Cicero, T. J., Kurtz, S. P., Rosenblum, A., et al. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.02.003 · Cited by 84
Comparison of costs and utilization among buprenorphine and methadone patients
Barnett, P. G. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02539.x · Cited by 73
Oliva, E. M., Harris, A. H. S., Trafton, J. A., & Gordon, A. J. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.10.004 · Cited by 66
Self-citationJones, E. S., Moore, B. A., Sindelar, J. L., O’Connor, P. G., Schottenfeld, R. S., & Fiellin, D. A. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.07.013 · Cited by 66
Lavonas, E. J., Banner, W., Bradt, P., Bucher‐Bartelson, B., Brown, K. R., Rajan, P. K., Murrelle, L., Dart, R. C., & Green, J. L. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.06.058 · Cited by 56
Oliva, E. M., Trafton, J. A., Harris, A. H. S., & Gordon, A. J. (2013) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2012.741167 · Cited by 55
Self-citationImplementation of buprenorphine in the Veterans Health Administration: Results of the first 3 years
Gordon, A. J., Trafton, J. A., Saxon, A. J., Gifford, A. L., Goodman, F., Calabrese, V. S., McNicholas, L. F., & Liberto, J. C. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.03.010 · Cited by 49
Self-citationClark, R. E., Baxter, J. D., BARTON, B. A., Aweh, G. N., O’Connell, E., & Fisher, W. H. (2014) · Health Services Research · doi:10.1111/1475-6773.12201 · Cited by 48
Chronic Pain and DepressionAmong Primary Care Patients Treated with Buprenorphine
Stein, M. D., Herman, D. S., Bailey, G. L., Straus, J. S., Anderson, B. J., Uebelacker, L. A., & Weisberg, R. B. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3212-y · Cited by 47
Bretteville‐Jensen, A. L., Lillehagen, M. E., Gjersing, L., & Andreas, J. B. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.12.002 · Cited by 41
Factors associated with Medicaid patients' access to buprenorphine treatment
Baxter, J. D., Clark, R. E., Samnaliev, M., Leung, G. Y., & Hashemi, L. (2011) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.02.002 · Cited by 28
Sublingual Buprenorphine for Chronic Pain
Rosen, K. D., Gutierrez, A., Haller, D. L., & Potter, J. S. (2013) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e318298ddad · Cited by 27
Adherence to Buprenorphine Treatment Guidelines in a Medicaid Program
Baxter, J. D., Clark, R. E., Samnaliev, M., Aweh, G. N., & O’Connell, E. (2015) · Substance Abuse · doi:10.1080/08897077.2014.991469 · Cited by 21
Farmer, C. M., Lindsay, D. L., Williams, J., Ayers, A., Schuster, J., Cilia, A., Flaherty, M. T., Mandell, T. W., Gordon, A. J., & Stein, B. D. (2015) · Substance Abuse · doi:10.1080/08897077.2015.1012613 · Cited by 17
Self-citationAn observational study of buprenorphine treatment of the prescription opioid dependent pain patient
Streltzer, J., Davidson, R., & Goebert, D. A. (2015) · American Journal on Addictions · doi:10.1111/ajad.12198 · Cited by 16
Buprenorphine for office-based treatment of patients with opioid addiction.
Manlandro, J. J. (2005) · PubMed · Cited by 14
Buprenorphine–naloxone buccal soluble film for the treatment of opioid dependence: current update
Soyka, M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.953479 · Cited by 5
Research works printed but not linked: 1
- Clark, 2013, Responses of state medicaid programs to buprenorphine diversion: Doing more harm than good J Am Med Assoc Intern M, ed, 173, 1571
Cited by
Sorted by citations
Development of a Cascade of Care for responding to the opioid epidemic.
Williams, A. R., Nunes, E. V., Bisaga, A., Levin, F. R., & Olfson, M. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2018.1546862 · Cited by 332
Samples, H., Williams, A. R., Olfson, M., & Crystal, S. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.09.001 · Cited by 246
Lo-Ciganic, W.-H., Huang, J. L., Zhang, H. H., Weiss, J. C., Wu, Y., Kwoh, C. K., Donohue, J. M., Cochran, G., Gordon, A. J., Malone, D. C., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.0968 · Cited by 228
Self-citationMauro, P. M., Gutkind, S., Annunziato, E. M., & Samples, H. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.3821 · Cited by 226
Williams, A. R., Samples, H., Crystal, S., & Olfson, M. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19060612 · Cited by 211
Metadata
- Authors
- Gordon, A. J., Lo-Ciganic, W.-H., Cochran, G., Gellad, W. F., Cathers, T., Kelley, D., & Donohue, J. M.
- Affiliations
- University of Arizona (US)
- VA Pittsburgh Healthcare System (US)
- University of Pittsburgh (US)
- Pennsylvania Department of Human Services (US)
- Corresponding author
- Gordon, Adam J.
- Venue
- Journal of Addiction Medicine
- Published
- 2015-11
- Volume
- 9
- Issue
- 6
- Pages
- 470-477
- ISSN
- 1932-0620 (ISSN-L)
- OpenAlex
- W1891063291
- Cited by
- 76
- References
- 35
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 8 · 2023: 7 · 2022: 5 · 2021: 15 · 2020: 10 · 2019: 11 · 2018: 8 · 2017: 4 · 2016: 2 · 2015: 2
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Addiction Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Pennsylvania Department of Human Services
- Centers for Disease Control and Prevention (U01CE002496)
- VA Pittsburgh Healthcare System
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- buprenorphine, opioid use disorder, Medicaid, quality of care, patterns of care, urine drug testing, benzodiazepine use, prescription drug use, racial disparities, sex disparities, age disparities
- MeSH terms
- Adolescent, Adult, Analgesics, Opioid, Buprenorphine, Female, Humans, Male, Medicaid, Middle Aged, Opioid-Related Disorders, Quality of Health Care, United States, Logistic Models, Prescription Drugs, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
